India's Shilpa Medicare rises after unit enters agreement with Orion Corporation

Shilpa Medicare

30/06/2026 06:27

** Shares of Indian pharmaceutical firm Shilpa Medicare SHME.NS rise as much as 5.6% to 605.6 rupees 
** The company's unit enters a co-development and supply agreement with Finland-based Orion Corporation ORNBV.HE for intravenous Nivolumab biosimilar
** Nivolumab is one of the world's most widely used cancer immunotherapies, says company
** Stock on avg rated "buy" by three analysts; median PT is 580 rupees, according to LSEG-compiled data
** Stock up 87.7%, YTD
     

 (Reporting by Abhirami G in Bengaluru)
 ((abhirami.g@thomsonreuters.com))